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Abstract
Background: Lipid accumulation has been shown to accelerate renal injury, and the intracellular accumulation of lipids may
be caused by alterations in synthesis as well as lipid uptake and efflux. We have investigated the role of cellular cholesterol
transport proteins including adenosine triphosphate binding cassette transporter A1 (ABCA1), G1 (ABCG1) and scavenger
receptor class B type I (SR-BI) in diabetic nephropathy.
Methods: Protein expression and the ability to mediate cholesterol efflux of ABCA1, ABCG1 and SR-BI was determined in
human renal mesangial cells and proximal tubular epithelial cells cultured under normal or high glucose conditions. Renal
expression of these cholesterol transporters was examined in a murine model of streptozotocin-induced type 1 diabetes.
Results: ABCA1, ABCG1 and SR-BI were expressed in both human renal mesangial cells and proximal tubular epithelial cells,
and mediated cholesterol efflux to apolipoprotein AI and HDL. In vitro, hyperglycemia reduced the expression and the
ability to mediate cholesterol efflux of all three cholesterol transporters (p,0.05). In vivo studies showed that intra-renal
accumulation of lipids was increased in diabetic mice, particularly in mice with nephropathy. This was associated with a
significant reduction in the expression of ABCA1, ABCG1 and SR-BI in the kidneys. These changes were already seen in
diabetic mice without nephropathy and preceded the development of nephropathy. Diabetic mice with nephropathy had
the lowest level of these cholesterol transporters.
Conclusion: Inducing diabetes with streptozotocin significantly reduced renal expression of ABCA1, ABCG1 and SR-BI.
Defects in cholesterol export pathway in renal cells could therefore promote cholesterol accumulation and might contribute
to the development of diabetic nephropathy.
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Introduction
Recent studies of progression of chronic kidney disease indicate
that, like atherosclerosis, lipid accumulation can contribute to
glomerular injury, and there is growing evidence that renal
accumulation of lipids play a role in the pathogenesis of diabetic
nephropathy [1–3]. Intra-renal accumulation of lipids has been
observed in diabetic patients and experimental animals [4,5], and
renal lipid accumulation may accelerate glomerulosclerosis and
interstitial fibrosis through lipid infiltration and induction of
oxidative stress, proinflammatory cytokines, and growth factors
[5–7]. The mechanism(s) for lipid accumulation in diabetic
nephropathy is not fully understood. The intracellular accumula-
tion of lipids and formation of lipid droplets may be caused by
alterations in synthesis [5,8] as well as lipid uptake [9,10] and
efflux.
Cellular cholesterol efflux occurs by transport mediated by
specific cholesterol transport proteins in addition to aqueous
diffusion [11]. Cholesterol transporters involved in cellular
cholesterol efflux include adenosine triphosphate binding cassette
transporter A1 (ABCA1), ABCG1, and scavenger receptor class B
type I (SR-BI) [11,12]. ABCA1 mediates cholesterol efflux to lipid-
free apolipoprotein AI (apo AI) and pre-b HDL, whereas both
ABCG1 and SR-BI mediate cholesterol efflux to mature HDL.
There is experimental evidence suggesting that changes in
cholesterol efflux may be involved in renal lipid accumulation.
Ruan et al. have shown that interleukin 1 beta promotes
intracellular lipid accumulation in mesangial cells by inhibiting
cholesterol efflux mediated by ABCA1 [13]. Mesangial cells are
specialized glomerular pericytes that share many properties with
macrophages [14]. Mesangial cells metabolize lipids similar to
macrophages, and they take on the appearance of foam cells after
accumulation of lipids [15]. Acute renal tubular injury can also
cause down regulation of ABCA1 and SR-BI [16]. Tang et al.
recently reported that ABCA1 expression was reduced in the
kidneys in diabetic NOD mice and was accompanied by an
increase in renal cholesterol [17]. The role of ABCG1 and SR-BI
in renal cellular cholesterol efflux in diabetic nephropathy has not
been determined. We have therefore evaluated the contribution to
cellular cholesterol efflux by the three cholesterol transporters in
human mesangial and proximal tubular epithelial cells (PTC) and
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investigated whether renal expression of these cholesterol trans-
porters is decreased in an animal model of diabetic nephropathy.
Materials and Methods
Cell culture
Primary human mesangial cells (NHMC) were purchased from
Lonza (Walkersville, MD) and cultured with Mesangial Cell
Growth Medium (Lonza, Walkersville, MD) supplemented with
5% FCS according to the supplier’s instructions. Normal proximal
tubular epithelial cells (PTC) immortalized with the human
papilloma virus 16 E6/E7 genes [18], HK-2 cells, were purchased
from ATCC (Manassas, VA) and cultured with DMEM/F12
medium (Life Technologies, Grand Island, NY) supplemented
with 5% FCS. Cells were fed every three days until 80% confluent.
Both cell culture media used contained 5 mM glucose. Cells were
incubated with or without additional dosages of D-glucose to cell
culture medium (final concentrations 5–55 mM) for 24 hours for
further Western blot analysis or cholesterol efflux.
Western blot analysis
At the end of the incubation with glucose, cells were lysed in M-
PER Mammalian Protein Extraction buffer (Pierce, Rockford, IL),
and protein concentrations were quantified by Lowry protein
assay (Bio-RAD, Hercules, CA). Aliquots of total cell lysates
obtained from NHMC or HK-2 cells under control or experi-
mental conditions, or from renal cortical tissue (20 mg total protein
as determined by the Lowry protein assay) were denatured with
sample loading buffer containing 5% b-mercaptoethanol (Invitro-
gen, Grand Island, NY). Samples were then heated at 95uC for
five minutes and subjected to SDS-PAGE followed by Western
blot. Membranes were extensively washed with TBS-T in between
all steps. Membranes were probed respectively with primary
antibodies of ABCA1 (Novus Biologicals, St. Louis, MO), ABCG1
(Santa Cruz Biotechnology, Dallas, TX), SR-BI (Novus Biologi-
cals, St. Louis, MO), CD36, SR-AI, LOX-1, LXR-a, and LXR-b
(Abcam, Cambridge, UK) (diluted 1:1,000), followed by the
respective secondary antibodies conjugated to HRP (Cell Signaling
Technology, Danvers, MA) (diluted 1:2,500). Protein bands were
visualized with ECL Plus according to the manufacturer’s
instructions (GE Healthcare, Buckinghamshire, UK).
Figure 1. Cellular cholesterol efflux to different cholesterol acceptors under basal condition. Cellular cholesterol efflux from mesangial
cells and tubular cells to apo AI, HDL and HDL with BLT-1 (HDL/BLT-1) under basal condition with 5 mM glucose in culture medium was presented as
means + SD from 3 separate experiments in duplicate, *p,0.05 and **p,0.01 vs. cell culture medium without any cholesterol acceptor; #p,0.05 vs.
HDL as cholesterol acceptor.
doi:10.1371/journal.pone.0105787.g001
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Cholesterol efflux
After incubating with various concentrations of D-glucose, cells
at 80% confluence were labeled with tracer [3H]-cholesterol
(1 mCi/well) for 16–20 hours at 37uC, and then equilibrated with
0.5% BSA for four hours before the addition of different
cholesterol acceptors. 10 mM of chemical that blocks lipid
transport (BLT-1, EMD Millipore Chemicals, San Diego, CA)
was added during equilibration to inhibit SR-BI activity as
indicated [19]. Apo AI (20 mg/ml, Biodesign, Memphis, TN),
HDL, HDL2 and HDL3 (25 mg protein/ml, BTI, Stoughton, MA)
were then used to induce cholesterol efflux from the labeled cells
for six hours. Radioactivity in media and cells were quantified by
Figure 2. Expression of cholesterol transporters under different concentrations of glucose. Human mesangial cells (A) and HK-2 cells (B)
were cultured under different conditions of glucose concentrations. Relative target protein band intensities were normalized against its b-actin and
were presented as means + SD by densitometric analysis from 3 separate experiments. *p,0.05 and **p,0.01 vs. cells with 5 mM glucose in culture
medium.
doi:10.1371/journal.pone.0105787.g002
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liquid scintillation counting using a Packard scintillation counter
(Perkin Elmer, Waltham, MA). The percentage of cholesterol
efflux from cells was calculated based on the radioactivity in the
media divided by the total radioactivity in cells and in media.
Ethics statement
All animal procedures were approved by the Institutional
Committee on the Use of Live Animals in Teaching and Research
at the University of Hong Kong. Animal welfare was monitored
Figure 3. Immunohistochemical images of cholesterol transporters in different groups of mice. Representative images of cholesterol
transporters ABCA1, ABCG1, and SR-BI in renal tissues from control, diabetic (DM), and diabetic nephropathy (DN) mice. Original magnification x400
(A). Image-based computer assisted analysis was performed to semi-quantify the amount of ABCA1, ABCG1 and SR-BI in the glomeruli and tubulo-
interstitium of control, DM and DN mice (B). Results were presented as mean + SD of data obtained from 5 mice per group. **p,0.01 or ***p,0.001,
control vs. DM; ###p,0.001, control vs. DN; 1p,0.05 or 11p,0.01, DM vs. DN.
doi:10.1371/journal.pone.0105787.g003
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daily and all efforts were made to minimize suffering. Any mouse
showing signs of limited movement or significant weight loss were
euthanized by intra-peritoneal injection of pentobarbitone
(150 mg/kg body weight).
Animal studies
Male DBA/2J mice at six to eight weeks of age were a kind gift
from Prof Y. L. Kwong (Department of Medicine, University of
Hong Kong) and received standard chow and water ad libitum.
After one week acclimatizing to their surroundings, mice were
fasted for six hours prior to intra-peritoneal injection of
streptozotocin (STZ, 50 mg/kg) in 10 mM citrate buffer,
pH 4.5, administered on five consecutive days. Diabetes mellitus
was confirmed by tail vein blood sampling of glucose concentra-
tion, measured with Accu-Chek Advantage II Glucostix test strips.
Spot urine was assessed weekly for albuminuria using Quanti-
Chrom albumin assay kit until sacrifice. Mice with diabetic
nephropathy, confirmed by proteinuria with urinary albumin
excretion rate .100 mg/dl on two occasions at least two days
apart were sacrificed (n= 5). Blood samples were obtained by
cardiac puncture and the kidneys harvested, decapsulated and
weighed. The left kidney was cut perpendicular to the long-axis
and one half of the kidney was snap frozen in OCT followed by
immersion in liquid nitrogen, while the second half was fixed in
10% neutral-buffered formalin followed by paraffin embedding.
Renal cortical tissue from the right kidney was separated from the
medulla and frozen at 280uC. Age- and sex-matched control
groups included non-diabetic male DBA/2J mice, and diabetic
mice without nephropathy (n= 5 per group). Serum creatinine and
urea levels were measured with QuantiChrom creatinine and urea
assay kits respectively, while serum triglyceride and cholesterol
were measured with Biomerieux triglyceride and cholesterol kits.
Cytochemical staining
Intra-renal expression of ABCA1, ABCG1 and SR-BI in control
and diabetic mice were determined using the peroxidase-anti-
peroxidase method with the same antibodies used in Western blot
and counterstained with hematoxylin as previously described
[20,21]. Intra-renal staining was semi-quantitatively assessed in at
least 15 separate images per mouse kidney, and the extent of
staining graded by two independent workers in a blinder manner
as follows: 0: 0–5% staining, 1: .5–25% staining, 2: .25–50%
staining, 3: .50–75% staining, 4: .75% staining.
Oil Red O staining
Frozen kidney sections were used for Oil Red O staining to
determine the renal accumulation of neutral fats. Briefly, frozen
kidney sections were first washed with tap water followed by rinses
with 60% isopropanol. Sections were then stained with freshly
prepared Oil Red O solution 15 minutes before nuclei staining
with alum haematoxylin. Stained sections were finally mounted in
glycerine jelly.
Statistics
All experiments were carried out for three times. Numerical
data were represented as mean 6 standard deviation (SD).
Dunnett t-tests were used to compare multiple diabetic groups
with the non-diabetic control as the reference group. Two-tailed
p,0.05 was considered statistically significant.
Results
All three cholesterol transporters (ABCA1, ABCG1 and SR-BI)
were expressed in human mesangial cells and in tubular HK-2
cells at basal state (Figure S1). Apo AI was able to stimulate
cellular cholesterol efflux from both cholesterol-laden mesangial
and tubular cells, suggesting that ABCA1 transporter was
functional (Figure 1). Cholesterol efflux experiments were also
performed with HDL, HDL2 or HDL3 as acceptor since both
ABCG1 and SR-BI could mediate cholesterol efflux to mature
HDL. There were no significant differences in cholesterol efflux
when the same amount of HDL, HDL2 and HDL3 was used
(Figure S2). The proportion of cholesterol efflux to HDL mediated
by SR-BI was represented by the degree of reduction in cholesterol
Figure 4. Oil Red O staining of cholesterol in renal tissues. Oil Red O staining of cholesterol in renal tissues from control, diabetic (DM), and
diabetic nephropathy (DN) mice. Original magnification x400. Box area is enlarged to compare cholesterol accumulation (denoted by arrows)
between control and diabetic mice (lower panels).
doi:10.1371/journal.pone.0105787.g004
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efflux after incubation with BLT-1 (an inhibitor of SR-BI), and the
remaining cholesterol efflux would likely be mainly mediated by
ABCG1 (Figure 1).
When mesangial cells and HK-2 cells were incubated under
high glucose conditions, the expressions of all three cholesterol
transporters were significantly decreased in a dose-dependent
manner (Figure 2). This was accompanied by a reduction in
cholesterol efflux to apo AI and to HDL (Figure S3), suggesting
that hyperglycemia might impair cellular cholesterol efflux by
reducing the expression of cholesterol transporters.
In vivo studies were performed to investigate the renal
expression of cholesterol transporters in diabetic mice. Plasma
lipids were only significantly increased in the diabetic mice with
nephropathy (DN) (Table 1). Glomerular abnormalities and
tubulo-interstitial changes were noted in mice with diabetic
nephropathy. Histological examination revealed that ABCA1,
ABCG1 and SR-BI were mainly expressed in renal tubules, and
there was a marked reduction in all three cholesterol transporters
in diabetic mice especially in the group with nephropathy
(Figure 3). Oil Red O staining revealed that lipid droplets
accumulated particularly at the renal tubules and was most
marked in the diabetic nephropathy group (Figure 4). Protein
expressions of ABCA1, ABCG1 and SR-BI were significantly
reduced in the kidneys from diabetic animals with the greatest
reduction seen in mice with nephropathy (Figure 5A). Interest-
ingly, the expression of LXR-a and LXR-b, the nuclear receptors
that act as important positive regulators of ABCA1 and ABCG1,
were also significantly reduced in the kidneys of diabetic mice
(Figure 5B). On the other hand, evaluation of the scavenger
receptors that mediated the uptake of lipoproteins including
CD36, SR-AI, and lectin-like oxidized lipoprotein receptor-1
(LOX-1) showed that only the expression of CD36 was increased
in diabetic animals (Figure 5C).
Discussion
Efflux of free cholesterol from cells is an early step of reverse
cholesterol transport. The role of the cholesterol transporters
ABCA1, ABCG1 and SR-BI in macrophage cholesterol efflux has
been extensively studied, and it has been shown that impaired
cellular cholesterol efflux is associated with atherosclerosis in
humans [12]. The role of cholesterol transporters and cellular
cholesterol efflux in renal disease is less clear. Previous studies have
shown that mesangial cell express ABCA1 and tubular cells
express both ABCA1 and SR-BI [13,16]. Although SR-BI can
mediate bi-directional cholesterol flux for instance, in the liver,
Zager et al. have demonstrated that SR-BI predominantly
functions as a cholesterol efflux pathway in tubular cells [16].
We have shown for the first time that all three cholesterol
transporters are expressed in human mesangial cells and proximal
tubular epithelial cells, and the expression of these cholesterol
transporters can be suppressed under high glucose conditions in
vitro. Song et al. recently reported that without the factor of high
fat, high glucose reduced ABCG1 expression in mouse mesangial
cells [22]. However, they did not find any changes in ABCA1
Figure 5. Renal expression of cholesterol uptake and efflux
proteins. Protein expression of ABCA1, ABCG1 and SR-BI (A), LXR-a,
LXR-b (B) and CD36, SR-AI, and LOX-1 (C) in kidneys from control,
diabetic (DM), and diabetic nephropathy (DN) mice. Relative target
protein band intensities were normalized against its b-actin and were
presented as means + SD by densitometric analysis from 5 mices per
group. *p,0.05 and **p,0.01 vs. Control.
doi:10.1371/journal.pone.0105787.g005
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expression, and this might be due to differences in cell lines and
experimental conditions used.
Studies in nephrotic rats have shown that increased kidney
tissue cholesterol was associated with reduced renal expression of
SR-BI whereas the expression of ABCA1 was either unchanged or
decreased [23,24]. In contrast, accumulation of lipid in the
remnant kidney in rats with chronic renal failure induced by 5/6
nephrectomy was accompanied by up-regulation of both ABCA1
and SR-BI [25]. Only the role of ABCA1 has previously been
examined in mouse models of type 1 diabetes and renal expression
of ABCA1 was reduced [17,26]. Proctor et al. suggested that the
accumulation of renal lipids was due to increased cholesterol and
fatty acid synthesis as well as reduced cholesterol efflux mediated
by ABCA1 [26]. However, it is not clear whether the reduction in
ABCA1 expression might be compensated by the up-regulation of
other cholesterol transporters.
Our study has provided new data on ABCG1 and SR-BI in
diabetic nephropathy. Firstly, we have shown that in addition to
ABCA1, ABCG1 and SR-BI were also expressed in both
mesangial cells and tubular cells, and we have evaluated the
distribution of these cholesterol transporters in the kidneys. All
three cholesterol transporters were most highly expressed in
proximal tubules of mouse kidneys, and were weakly detected in
the glomeruli. Secondly, inducing diabetes with streptozotocin
significantly reduced renal expression of not only ABCA1 but also
ABCG1 and SR-BI, and these changes preceded the development
of diabetic nephropathy. Since all three transporters were
involved, cellular cholesterol efflux to both apo AI and HDL
would be affected. Defects in cholesterol export pathway in renal
cells could therefore promote cholesterol accumulation. In our
study, diabetic mice with nephropathy had the lowest level of
expression of all three cholesterol transporters and this was
accompanied by an increase in CD36. Hence, an increase in
modified lipoproteins uptake by CD36 coupled with reduction in
lipid efflux pathways would contribute to the increased amount of
lipid droplets and foam cells in glomeruli and tubulointerstitium of
diabetic mice.
In conclusion, the expression of ABCA1, ABCG1 and SR-BI in
mesangial cells and tubular cells were significantly decreased
under hyperglycemic conditions in vitro, and renal expression of
these cholesterol transporters was reduced in diabetic mice with
nephropathy. Our results suggest that impaired cellular cholesterol
efflux in the kidney might contribute to the development of
diabetic nephropathy.
Supporting Information
Figure S1 Basal expression of cholesterol transporters
in mesangial cells and tubular HK-2 cells. Relative target
protein band intensities of ABCA1 (a), ABCG1 (b) and SR-BI (c)
were normalized against its b-actin respectively and were
presented as means + SD by densitometric analysis from 3
separate experiments.
(DOCX)
Figure S2 Cellular cholesterol efflux of mesangial cells
and tubular HK-2 cells. Cellular cholesterol efflux from
mesangial cells and tubular cells to HDL, HDL2 and HDL3 was
presented as means + SD from 3 separate experiments in
duplicate. No significant difference was seen between cholesterol
efflux to HDL, HDL2 and HDL3.
(DOCX)
Figure S3 Cellular cholesterol efflux of mesangial cells
and tubular HK-2 cells under different concentrations of
glucose. Cellular cholesterol efflux to apo AI and HDL from
mesangial cells (a) and tubular cells (b) cultured under different
conditions of glucose concentrations were presented as means +
SD from 3 separate experiments in duplicate, *p,0.05 and **p,
0.01 vs. cells with 5 mM glucose in culture medium.
(DOCX)
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